Literature DB >> 19815565

On to the road to degradation: atherosclerosis and the proteasome.

Joerg Herrmann1, Lilach O Lerman, Amir Lerman.   

Abstract

Protein metabolism is a central element of every living cell. The ubiquitin-proteasome system (UPS) is an integral part of the protein metabolism machinery mediating post-transcriptional processing and degradation of the majority of intracellular proteins. Over the past few years, remarkable progress has been made in our understanding of the role of the UPS in vascular biology and pathobiology, particularly atherosclerosis. This review reflects on the recent developments from the effects on endothelial cells and the initial stage of atherosclerosis to the effects on vascular smooth muscle and the progression stage of atherosclerosis and finally to the effects on cell viability and the complication stage of atherosclerosis. It will conclude with the integration of the available information in a synoptic view of the involvement of the UPS in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815565      PMCID: PMC2797451          DOI: 10.1093/cvr/cvp333

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  99 in total

1.  A proteasomal stress response: pre-treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injury.

Authors:  Chul-Sang Lee; Lee Y Tee; Timothy Warmke; Anant Vinjamoori; Aili Cai; Anne M Fagan; B Joy Snider
Journal:  J Neurochem       Date:  2004-11       Impact factor: 5.372

2.  Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells.

Authors:  Silke Meiners; Antje Ludwig; Mario Lorenz; Henryk Dreger; Gert Baumann; Verena Stangl; Karl Stangl
Journal:  Free Radic Biol Med       Date:  2006-03-31       Impact factor: 7.376

3.  Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.

Authors:  Cord Naujokat; Carsten Berges; Alexandra Höh; Hubert Wieczorek; Dominik Fuchs; Jörg Ovens; Marion Miltz; Mahmoud Sadeghi; Gerhard Opelz; Volker Daniel
Journal:  Immunology       Date:  2006-11-03       Impact factor: 7.397

4.  Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase.

Authors:  Tian Xia; Christiana Dimitropoulou; Jingmin Zeng; Galina N Antonova; Connie Snead; Richard C Venema; David Fulton; Shuibing Qian; Cam Patterson; Andreas Papapetropoulos; John D Catravas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-09-14       Impact factor: 4.733

5.  Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity.

Authors:  Raffaele Marfella; Mario Siniscalchi; Michele Portoghese; Clara Di Filippo; Franca Ferraraccio; Concetta Schiattarella; Basilio Crescenzi; Paolo Sangiuolo; Giuseppe Ferraro; Silvio Siciliano; Francesca Cinone; Gennaro Mazzarella; Simone Martis; Mario Verza; Ludovico Coppola; Francesco Rossi; Michele D'Amico; Giuseppe Paolisso
Journal:  Hypertension       Date:  2007-02-19       Impact factor: 10.190

6.  The functional variant rs1048990 in PSMA6 is associated with susceptibility to myocardial infarction in a Chinese population.

Authors:  Xin Liu; Xingyu Wang; Yue Shen; Lijun Wu; Xiaoyang Ruan; Klaus Lindpaintner; Salim Yusuf; James C Engert; Sonia Anand; Xuerui Tan; Lisheng Liu
Journal:  Atherosclerosis       Date:  2009-02-12       Impact factor: 5.162

7.  Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice.

Authors:  Jozef Leo Van Herck; Guido R Y De Meyer; Wim Martinet; Hidde Bult; Christiaan J Vrints; Arnold G Herman
Journal:  Basic Res Cardiol       Date:  2009-08-20       Impact factor: 17.165

8.  SNPs of PSMA6 gene--investigation of possible association with myocardial infarction and type 2 diabetes mellitus.

Authors:  T Sjakste; I Poudziunas; E Ninio; C Perret; V Pirags; V Nicaud; M Lazdins; A Evanss; C Morrison; F Cambien; N Sjakste
Journal:  Genetika       Date:  2007-04

Review 9.  On and off: proteasome and TGF-beta signaling.

Authors:  Fan Zhang; Marikki Laiho
Journal:  Exp Cell Res       Date:  2003-12-10       Impact factor: 3.905

10.  Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis.

Authors:  Davide Genini; Giuseppina M Carbone; Carlo V Catapano
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more
  13 in total

Review 1.  Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular disease.

Authors:  Feilong Wang; Amir Lerman; Joerg Herrmann
Journal:  Am J Cardiovasc Dis       Date:  2015-03-10

2.  The SCFFBXO3 ubiquitin E3 ligase regulates inflammation in atherosclerosis.

Authors:  Divay Chandra; James Londino; Shaun Alexander; Joseph S Bednash; Yingze Zhang; Robert M Friedlander; Grant Daskivich; Diane L Carlisle; William R Lariviere; Ana Carolina Igami Nakassa; Mark Ross; Claudette St Croix; Toru Nyunoya; Frank Sciurba; Bill Chen; Rama K Mallampalli
Journal:  J Mol Cell Cardiol       Date:  2018-11-16       Impact factor: 5.000

3.  Effect of Proteasome Inhibitor on Vascular Cell Adhesion Molecule-1 (VCAM-1) and Intercellular Adhesion Molecule-1 (ICAM-1) Expressions in Rat Model of Atherosclerosis.

Authors:  Ismawati Ismawati; Ilhami Romus; Mukhyarjon Mukhyarjon; Afra Muthya
Journal:  Rep Biochem Mol Biol       Date:  2022-01

Review 4.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

Review 5.  Arterial events in cancer patients-the case of acute coronary thrombosis.

Authors:  Ohad Oren; Joerg Herrmann
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 6.  Proteasome biology and therapeutics in cardiac diseases.

Authors:  Sanket Kumar Shukla; Khadija Rafiq
Journal:  Transl Res       Date:  2018-09-28       Impact factor: 7.012

7.  Acute decreases in proteasome pathway activity after inhalation of fresh diesel exhaust or secondary organic aerosol.

Authors:  Howard M Kipen; Sampada Gandhi; David Q Rich; Pamela Ohman-Strickland; Robert Laumbach; Zhi-Hua Fan; Li Chen; Debra L Laskin; Junfeng Zhang; Kiran Madura
Journal:  Environ Health Perspect       Date:  2010-12-15       Impact factor: 9.031

Review 8.  Defective Protein Catabolism in Atherosclerotic Vascular Inflammation.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  Front Cardiovasc Med       Date:  2017-12-07

9.  Metabolomic Quantitative Trait Loci (mQTL) Mapping Implicates the Ubiquitin Proteasome System in Cardiovascular Disease Pathogenesis.

Authors:  William E Kraus; Deborah M Muoio; Robert Stevens; Damian Craig; James R Bain; Elizabeth Grass; Carol Haynes; Lydia Kwee; Xuejun Qin; Dorothy H Slentz; Deidre Krupp; Michael Muehlbauer; Elizabeth R Hauser; Simon G Gregory; Christopher B Newgard; Svati H Shah
Journal:  PLoS Genet       Date:  2015-11-05       Impact factor: 5.917

10.  Changes in expression of proteasome in rats at different stages of atherosclerosis.

Authors:  Fadil Oenzil; Eti Yerizel
Journal:  Anat Cell Biol       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.